Vertex Pharmaceuticals Incorporated shares owned by Morgan Stanley
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $1.5B | 3.3M | 468.78 |
| 2024-03-31 | $1.3B | 3.2M | 418.06 |
| 2023-12-31 | $1.2B | 3.0M | 406.92 |
| 2023-09-30 | $998M | 2.9M | 347.74 |
| 2023-06-30 | $979M | 2.8M | 351.91 |
| 2022-12-31 | $745M | 2.6M | 288.78 |
| 2022-06-30 | $515M | 1.8M | 281.78 |
| 2022-03-31 | $216M | 826k | 260.93 |
| 2021-06-30 | $246M | 1.2M | 201.64 |
| 2020-12-31 | $217M | 918k | 236.12 |
| 2020-09-30 | $210M | 774k | 271.72 |
| 2020-06-30 | $200M | 689k | 290.07 |
| 2020-03-31 | $161M | 676k | 237.66 |
| 2019-12-31 | $169M | 771k | 219.37 |
| 2019-09-30 | $96M | 566k | 169.49 |
| 2019-03-31 | $170M | 511k | 333.33 |
| 2018-12-31 | $124M | 747k | 165.84 |
| 2018-09-30 | $133M | 691k | 192.34 |
| 2018-06-30 | $106M | 622k | 170.24 |
| 2018-03-31 | $129M | 793k | 162.98 |
| 2017-12-31 | $194M | 1.3M | 149.86 |
| 2017-03-31 | $66M | 604k | 109.35 |
| 2016-12-31 | $21M | 278k | 73.53 |
| 2016-09-30 | $63M | 726k | 87.10 |
| 2016-06-30 | $17M | 197k | 85.73 |
| 2016-03-31 | $29M | 359k | 79.66 |
| 2015-12-31 | $39M | 310k | 126.27 |
| 2015-09-30 | $21M | 197k | 104.14 |
| 2015-06-30 | $0 | 197k | 0.00 |
| 2014-12-31 | $34M | 284k | 118.85 |
| 2014-09-30 | $29M | 257k | 112.23 |
| 2014-06-30 | $37M | 391k | 94.89 |
| 2014-03-31 | $13M | 186k | 70.54 |
| 2013-12-31 | $19M | 256k | 74.30 |
| 2013-09-30 | $30M | 389k | 75.82 |
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated